Robert Bruce
Chief Executive Officer at Soricimed Biopharma, Inc.
Profile
Robert Bruce is currently the Chief Executive Officer at Soricimed Biopharma, Inc. since 2019.
Prior to this, he was the President & Chief Executive Officer at Beresford Box Co. Inc.
Robert Bruce active positions
Companies | Position | Start |
---|---|---|
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Chief Executive Officer | 17/07/2019 |
Former positions of Robert Bruce
Companies | Position | End |
---|---|---|
Beresford Box Co. Inc.
Beresford Box Co. Inc. Miscellaneous Commercial ServicesCommercial Services Beresford Box Co. Inc. designs and manufactures carton and packaging products. It produces folding paperboard-based packaging, specializing in high-quality, multi-colored printed cartons. The firm also provides other value-added services to its customers, including packaging design, in-house die and print-plate manufacturing, and commercial printing. The company was founded in 1964 and is headquartered in Waterloo, Canada. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Beresford Box Co. Inc.
Beresford Box Co. Inc. Miscellaneous Commercial ServicesCommercial Services Beresford Box Co. Inc. designs and manufactures carton and packaging products. It produces folding paperboard-based packaging, specializing in high-quality, multi-colored printed cartons. The firm also provides other value-added services to its customers, including packaging design, in-house die and print-plate manufacturing, and commercial printing. The company was founded in 1964 and is headquartered in Waterloo, Canada. | Commercial Services |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert Bruce